Back to search

Michigan State University

Translational biomarker studies of Alzheimer's disease and mild cognitive impairment

Abstract

dc:description

Alzheimer's disease (AD) is a degenerative brain disorder and the most common cause of dementia, affecting more than 5 million Americans and 30 million people worldwide. In this dissertation, I describe two studies investigating imaging and non-imaging biomarkers for the diagnosis of AD. Two groups of patients were studied: individuals with a clinical diagnosis of AD and individuals with mild cognitive impairment (MCI), an intermediate state between normal cognitive aging and AD. Patients with MCI have an increased risk of developing AD-type dementia. Although many MCI patients develop dementia, other individuals with MCI stay cognitively stable or even regain normal cognitive status. In the first study, diffusion tensor imaging (DTI) was used to study the effects of AD and MCI on the integrity of limbic white matter pathways. Declines in the integrity of the fornix and the descending cingulum were detectable in both AD and MCI patients. Decreased integrity of the descending cingulum was associated with decreased glucose metabolism in the posterior cingulate cortex (PCC), the earliest detectable sign of AD on positron emission tomography scans. These findings suggest that the integrity of limbic white matter pathways, as measured by DTI, may serve as a useful biomarker for the diagnosis of AD. These findings also support the "disconnection hypothesis" as a mechanism for the PCC hypometabolism observed in patients with incipient AD. In the second study, we used statistical pattern classification methods and data from the Alzheimer's Disease Neuroimaging Initiative to develop a prognostic model of dementia for patients with MCI. More than 750 variables spanning clinical, magnetic resonance imaging (MRI), and plasma proteomic data were considered as potential predictors of progression from MCI to dementia. A model based on a small number of clinical and MRI predictors was found to have good predictive performance. I describe the characteristics of the model, including its advantages and limitations. The prognostic model of dementia developed here provides a non-invasive, cost-effective approach that can be used to improve the selection of MCI patients in clinical trials and identify high-risk MCI patients for early anti-AD treatment.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Korolev, Igor O.
Contributors dc:contributor
  • Bozoki, Andrea
  • Symonds, Laura
  • Zhu, David
  • Jin, Rong

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language
English

Identifiers

dc:identifier.*
Identifier
etd:394
isbn:9781303268052
isbn:1303268051
oclc:931743469
umi:3588610
local:Korolev_grad.msu_0128D_12118

Chain of custody

source
Harvested from
Michigan State University
Base URL
d.lib.msu.edu/oai
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Korolev, Igor O.. Translational biomarker studies of Alzheimer's disease and mild cognitive impairment. 2013. https://doi.org/doi:10.25335/6tny-3e72